- 2013
-
Press releases - 27.11.2013
Mechanics and genetics: an indispensable cocktail for embryonic development
In the fruit fly Drosophila and zebrafish, mechanical strain may activate the genetic cascade that initiates the formation of the future organs during embryogenesis. A discovery made by Emmanuel Farge (Inserm Research Director at Institut Curie) and his staff might explain the emergence of the first complex organisms more than 570 million years ago.
-
What's on? - 27.11.2013
30 years of aids research
AIDS stands for acquired immunodeficiency syndrome. This sexually transmitted infection is caused by a virus called HIV which attacks the immune system, making the body less resistant to normally benign diseases.WHO reports that more and more adolescents are affected by AIDS. “Over two million adolescents aged 10 to 19 live with HIV, and many of […]
-
What's on? - 25.11.2013
1 December 2013: World AIDS Day
What research progress has been made? According to the WHO, 34 million people are currently infected by HIV. Only 1.3 million patients from poor countries have access to treatment and there are 6,800 new cases of HIV each day. The Human Immunodeficiency Virus (HIV) attacks the cells in the immune system, either destroying them or […]
-
Press releases - 22.11.2013
Stanislas Dehaene is awarded the Inserm Grand Prix for 2013
The annual Inserm awards ceremony will take place on Monday 2 December at the Collège de France. On this occasion, eight prizes will be awarded to women and men who contribute daily to the scientific excellence of the Institute.
Stanislas Dehaene will be awarded the Inserm Grand Prix for his body of work on consciousness, Ogobara Doumbo will receive the International Prize for his research on malaria, and Daniel Louvard will be awarded the Honorary Prize for his work on cancer. -
Press releases - 22.11.2013
Chemotherapy: when our intestinal bacteria provide reinforcement
Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (French National Agronomic Research Institute) has led to a rather surprising discovery on the manner in which cancer chemotherapy treatments act more effectively with the help of the intestinal flora (also known as the intestinal microbiota).
-
Press releases - 21.11.2013
Where and how are fear-related behaviours and anxiety disorders controlled?
A team of researchers at Inserm led by Cyril Herry (Inserm Unit 862, “Neurocentre Magendie,” Bordeaux) has just shown that interneurons located in the forebrain at the level of the prefrontal cortex are heavily involved in the control of fear responses. Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour.
-
Press releases - 18.11.2013
Cancer treatment: a step towards personalized chronotherapy
An international study conducted on mice and coordinated by researchers from Inserm, CNRS and Université Paris-Sud[1] has paved the way towards personalized chronotherapy treatments. In an article published in the journal Cancer Research, the team has shown that the timing of optimal tolerance to irinotecan, a widely used anti-cancer drug, varies by 8 hours depending on the sex and genetic background of mice. They then developed a mathematical model that makes it possible to predict, for each animal, the optimal timing for administering the drug.
-
Press releases - 18.11.2013
Inserm and Fondation ARSEP organize the third meeting between researchers and patients
Multiple Sclerosis (MS) is a debilitating neurological disease which affects 80,000 individuals in France. At the moment, there is no known cause or cure. There are only treatments for the disease symptoms. Given the need to keep patients informed of progress in research, Inserm and Fondation ARSEP organise national meetings between researchers and patients every two years.
-
What's on? - 13.11.2013
An acidic diet may increase the risk of type 2 Diabetes
Diabetes mellitus is characterised by a permanently high level of blood sugar. There are two types, known as type 1 (once known as juvenile diabetes or insulin-dependent diabetes) and type 2 (formerly noninsulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes, which concerns 90% of diabetics). World Diabetes Day, launched in 2011, will be held on Thursday […]
-
Press releases - 13.11.2013
Launch of third season of GrippeNet.fr
Launched two years ago by the French GPs Sentinelles network (a joint research unit involving Inserm and the Université Pierre et Marie Curie) and the French Institute for Public Health Surveillance, the GrippeNet.fr website is back for a third consecutive year.